ERGO Share PerformanceMore
|52 week high||172.00 08/01/16|
|52 week low||117.00 16/09/16|
|52 week change||-51.50 (-30.03%)|
|4 week volume||333,359 04/09/16|
Latest News« previous» nextMore
26/09/2016 - 07:07 StockMarketWire
26/09/2016 - 07:00 RNS
RNS Number: 7528K Ergomed plc 26 September 2016 PRESS RELEASE Unaudited Interim results for the six months ended 30 June 2016 Strong first half financial performance - revenues up 21% and gross profit up 26% 19 million new contracts signed resulting in a backlog of 60 million Acquisitions of O+P and GASD strengthens service business Acquisition of Ha...
22/09/2016 - 09:22 StockMarketWire
Ergomed says that following its recent acquisitions of Dr Oestreich + Partner and Gesellschaft fr angewandte Statistik + D...
22/09/2016 - 07:00 RNS
RNS Number: 4981K Ergomed plc 22 September 2016 Ergomed's full service contract win validates strategic rationale of recent acquisitions London, UK - 22 September 2016: Ergomed plc, (LSE: ERGO or 'Ergomed' or "the Group") announces that, following its recent acquisitions of Dr. Oestreich + Partner GmbH ('O+P') and Gesellschaft fr angewandte Statistik + Date...
16/09/2016 - 10:56 RNS
RNS Number: 0683K Ergomed plc 16 September 2016 GBC Research initiates coverage of Ergomed plc with a "buy" recommendation and target price of GBP 2.73 (EUR 3.22) per share Potential upside of more than 128% compared to AIM closing price of GBP 1.20 the day prior to publication of the report GBC's recommendation based on Ergomed's profitability, with...
08/09/2016 - 07:41 StockMarketWire
Ergomed has completed recruitment in a phase IIa clinical trial of lorediplon in patients with insomnia disorder. Under Er...
08/09/2016 - 07:00 RNS
RNS Number: 2253J Ergomed plc 08 September 2016 PRESS RELEASE FOR IMMEDIATE RELEASE Ergomed completes recruitment of Phase IIa clinical trial of lorediplon in insomnia in collaboration with co-development partner Ferrer Results expected at the end of the year London, UK - 8 September 2016: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company...
07/09/2016 - 11:30 RNS
RNS Number: 2000J Ergomed plc 07 September 2016 PRESS RELEASE FOR IMMEDIATE RELEASE Notice of Interim Results London, UK - 7 September 2016: Ergomed plc (LSE: ERGO) ('Ergomed' or 'the Company'), a profitable UK-based group dedicated to the provision of specialised services to the pharmaceutical industry and the development of new drugs, w...
|Dividend yield||0 %|
Latest discussion posts More
“We will be hosting a webinar with the management of Ergomed tomorrow (Tuesday 27th September) at 11.15. There will be a presentation of the interim results lasting around ...”▼
Codes & Symbols
|Symbols||ERGO, LSE:ERGO, ERGO.L, ERGO:LN, LON:ERGO, XLON:ERGO|